Nippon India Pharma Fund G
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund G
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 10-May-2004
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 7898.24
Nippon India Pharma Fund G - Nav Details
Nav Date
: 13-Apr-2026
NAV [Rs.]
: 496.8099
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
:
Nippon India Pharma Fund G- NAV Chart
Nippon India Pharma Fund G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 2.23 | -1.24 | -2.17 | -3.15 | 5.47 | 21.03 | 13.71 | 19.55 |
| Category Avg | 2.75 | 0.06 | -1.42 | -3.67 | 6.94 | 22.38 | 14.36 | 12.26 |
| Category Best | 3.53 | 5.15 | 3.34 | 1.53 | 14.49 | 26.31 | 16.87 | 26.06 |
| Category Worst | 2.17 | -1.46 | -6.22 | -7.7 | -0.52 | 17.89 | 10.54 | -7.67 |
Nippon India Pharma Fund G- Latest Dividends
No Records Found
Nippon India Pharma Fund G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.92 | 6256349 | 1,099.36 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 8.45 | 2883991 | 667.32 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.41 | 850754 | 505.94 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.96 | 3749746 | 470.55 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.42 | 3495054 | 427.86 |
| Equity | Apollo Hospitals | Healthcare Services | 5.15 | 548795 | 407.15 |
| Equity | Medplus Health | Retailing | 3.86 | 3627277 | 304.65 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.36 | 946323 | 265.45 |
| Equity | Max Healthcare | Healthcare Services | 3.24 | 2658082 | 255.78 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.15 | 2886684 | 248.65 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.15 | 2555745 | 248.41 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.87 | 1131195 | 226.89 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.81 | 1702630 | 222.09 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.77 | 1364742 | 218.52 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.64 | 913226 | 208.48 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.43 | 74187 | 192.25 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.17 | 323678 | 171.51 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.09 | 799649 | 165.07 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.02 | 1218224 | 159.84 |
| Equity | Thyrocare Tech. | Healthcare Services | 1.94 | 4392120 | 153.52 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.90 | 318249 | 150.22 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.72 | 800549 | 135.78 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.67 | 823911 | 132.26 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.51 | 746337 | 119.07 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.16 | 213659 | 91.83 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.12 | 3896349 | 88.81 |
| Equity | Fortis Health. | Healthcare Services | 1.11 | 1103889 | 87.75 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.93 | 230272 | 73.91 |
| Equity | Syngene Intl. | Healthcare Services | 0.93 | 1883372 | 73.43 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.89 | 1515264 | 70.62 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.88 | 1058503 | 69.46 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.67 | 1469374 | 53.02 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.62 | 62568 | 48.58 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.38 | 1834924 | 30.09 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.14 | 111738 | 11.37 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,40,030.99
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
